Navigation Links
Stem Cells Hold Promise for Muscular Dystrophy
Date:7/10/2008

Injections helped restore damaged muscle in mice, researchers report

THURSDAY, July 10 (HealthDay News) -- Researchers are reporting that they've managed to repair damaged muscle in mice with a form of muscular dystrophy by injecting them with specialized stem cells from skeletal muscle.

There's no guarantee that the treatment will translate to humans with the disease, said study author Amy Wagers, an assistant professor in Harvard University's Stem Cell and Regenerative Biology Department.

Still, the findings are going to help scientists "move forward very quickly with human stem cells," she said. "It is an important step."

There are more than 30 kinds of muscular dystrophy, all genetic diseases that cause skeletal muscles to degenerate. The most common form, Duchenne muscular dystrophy, mainly affects boys and is caused by the lack of a protein that helps muscles stay intact.

Many children with the disease cannot walk and must live on respirators. The disease is usually fatal by early adulthood.

The best treatment is with steroids, which slow the immune response that causes much of the muscle scarring, said Paul Muhlrad, research program coordinator with the Muscular Dystrophy Association. "However, there are a number of promising experimental therapies under development, including gene and cell therapies and treatment with a high-tech drug," he said.

In the new study, Wagers and her colleagues turned to purified stem cells that create muscle. The cells came from healthy adult mice and were injected into mice with a disease that scientists consider to be the equivalent to Duchenne muscular dystrophy.

The findings were published in the July 11 issue of Cell.

Like a replacement division sent to replace exhausted soldiers, the stem cells restored muscle. "They actually came in and started making muscle," she said.

The stem cells even left a supply of reserve cells for future use, Wagers said. These reserve cells were a bonus: "They can be activated if needed to repair damage later," she explained.

There is one hitch, however. The treatment probably won't help restore muscle in the heart, which some forms of muscular dystrophy target.

For now, the next step is to see if the approach will work in humans, Wagers said.

Muhlrad said the study is exciting, especially because it relies upon stem cells that come from adults, not embryos. Researchers have been working on a similar treatment using embryonic stem cells, but "that method entails some technical and ethical challenges," he said.

As for humans, the potential for the new stem cell treatment is unknown.

"Researchers will have to devise effective methods for isolating the required numbers of cells from human donors, for delivering those cells to all the affected muscles in patients, and for ensuring that the transplanted cells are not rejected by the recipient's immune system," Muhlrad said.

In general, "stem cell treatment is certainly not yet ready for prime time for muscular dystrophy, though there have been a number of promising preclinical studies in animals, which we're hopeful will enter human clinical trials soon."

More information

Learn more about muscular dystrophy from the National Institute of Neurological Disorders and Stroke.



SOURCES: Amy Wagers, Ph.D., principal investigator, Joslin Diabetes Center, and assistant professor, Stem Cell and Regenerative Biology Department, Harvard University, Boston; Paul Muhlrad, Ph.D., research program coordinator, Muscular Dystrophy Association, Tucson, Ariz. July 11, 2008, Cell


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Brain cells work differently than previously thought
3. Embryonic Stem Cells Repair Human Heart
4. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
5. Circulating fats kill transplanted pancreas cells, study shows
6. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
7. Melanoma drug revs immune cells but cancer cells ignore it
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Embryonic stem cells used to grow cartilage
10. Molecular probe paints cancer cells in living animals, Stanford researchers find
11. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem Cells Hold Promise for Muscular Dystrophy
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... clearly shows that over the last decade, student well-being has seriously declined. "When ... boxes of formal education, join the Islamic State to turn the historic multi-ethnic ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... , April 20, 2017 Research ... America Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, ... Segment Forecasts, 2014 - 2025" report to their offering. ... The Latin American ... 21.0 billion by 2025 Low drug registration cost ...
(Date:4/19/2017)... -- The Mobile X-Ray product segment is the most attractive ... forecast period Mobile X-Ray segment is the largest ... devices market, which is estimated to be valued at more ... of 7% over the forecast period. Mobile X-Ray segment is ... 100 Mn in 2017 over 2016. The segment,s revenue in ...
Breaking Medicine Technology: